Articles On Avita Medical (ASX:AVH)
Title | Source | Codes | Date |
---|---|---|---|
Top 10 at 10: These ASX lithium and gold stocks are making hay on Monday
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | AVH | 1 year ago |
ScoPo’s Powerplays: ASX health stocks rise as Proteomics inks Sonic deal
ASX health stocks rise in the past five days outperforming broader markets Avita Medical product sales up 40% on pcp to US$10.5 million in Q1 FY23 Proteomics International Laboratories inks a deal with Sonic Healthcare USA Healthcare and... |
Stockhead | AVH | 1 year ago |
Market Highlights: Fresh US banking crisis, UK rate at 15-year high, and 5 ASX small caps to watch today
The ASX is set to fall today on renewed US banking crisis The BoE raised its rates to highest in 15 years Gold was down despite Wall Street selloff The ASX is poised to open lower on Friday as the US banking crisis reared its ugly head... |
Stockhead | AVH | 1 year ago |
Dr Boreham’s Crucible: Impedimed
Tim Boreham reports a change in CEO has given cancer monitoring biotech Impedimed a new lease of life. By Tim Boreham ASX code: ((IPD)) Share price: 18.5 cents Shares on issue: 1,787,664,914 Market cap: $330.7 million Chief executive office... |
FNArena | AVH | 1 year ago |
5 top ASX shares that would have more than doubled your money in 2023
Investing in ASX shares has been a profitable venture for most investors in 2023. Since the opening bell on 3 January, the All Ordinaries Index (ASX: XAO) has gained 5%. And that figure doesnât include any dividend payouts made by many o... |
Motley Fool | AVH | 1 year ago |
The Overnight Report: Here We Go Again?
World Overnight SPI Overnight 7316.00 – 38.00 – 0.52% S&P ASX 200 7322.00 – 8.40 – 0.11% S&P500 4071.63 – 65.41 – 1.58% Nasdaq Comp 11799.16 – 238.05 – 1.98% DJIA 33530.83 – 344.57 – 1.02% S&P500 VIX 18.76 + 1.87 1... |
FNArena | AVH | 1 year ago |
Weekly Ratings, Targets, Forecast Changes – 21-04-23
By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquarie, Morgan Stanley, Morgans, Ord Minnett, Shaw and Partners and UBS. For the purpose of bro... |
FNArena | AVH | 1 year ago |
The Overnight Report: Bring It On
World Overnight SPI Overnight 7376.00 – 17.00 – 0.23% S&P ASX 200 7381.50 + 19.90 0.27% S&P500 4151.32 + 13.68 0.33% Nasdaq Comp 12157.72 + 34.26 0.28% DJIA 33987.18 + 100.71 0.30% S&P500 VIX 16.95 – 0.12 – 0.70%... |
FNArena | AVH | 1 year ago |
Weekly Ratings, Targets, Forecast Changes – 14-04-23
By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquarie, Morgan Stanley, Morgans, Ord Minnett, Shaw and Partners and UBS. For the purpose of bro... |
FNArena | AVH | 1 year ago |
ScoPo’s Powerplays: ASX health stocks rise, ImpediMed surges 99% on NCCN guidelines update
ASX health stocks rise 0.97% in the past five days in line with broader markets Impedimed up 99% after BIS tech named in latest US NCCN guidelines for lymphoedema EBR Systems to release top line results at cardiac conference Heart Rhythm... |
Stockhead | AVH | 1 year ago |
Dr Boreham’s Crucible: Avita Medical
Tim Boreham highlights the global addressable market opportunity for Avita Medical's skin graft technology, made famous by the Bali bombings. By Tim Boreham ASX code: AVH (Chess depositary instruments); Nasdaq code: RCEL (US shares) Shares... |
FNArena | AVH | 1 year ago |
After Neuren’s success, which other ASX health stocks are knocking on the US FDA door?
Several ASX health stocks are seeking US FDA approval for drugs/devices in the near future Telix Pharmaceuticals is chasing renal cancer imaging approval for TLX-250 CDx Aroa is awaiting an FDA decision on the required regulatory pathway... |
Stockhead | AVH | 1 year ago |
7 ASX All Ordinaries shares smashing new 52-week highs today
It’s been a pretty positive day for ASX shares and the All Ordinaries Index (ASX: XAO) so far this Thursday. After a rocky start, the All Ords is tentatively in the green at the time of writing, having put on 0.12%, which lifts the Index t... |
Motley Fool | AVH | 1 year ago |
The Overnight Report: The Need For Speed
World Overnight SPI Overnight 7272.00 – 60.00 – 0.82% S&P ASX 200 7364.70 + 36.10 0.49% S&P500 3986.37 – 62.05 – 1.53% Nasdaq Comp 11530.33 – 145.41 – 1.25% DJIA 32856.46 – 574.98 – 1.72% S&P500 VIX 19.59 + 0.98 5.... |
FNArena | AVH | 1 year ago |
The Overnight Report: All Quiet
World Overnight SPI Overnight 7279.00 – 12.00 – 0.16% S&P ASX 200 7328.60 + 45.00 0.62% S&P500 4048.42 + 2.78 0.07% Nasdaq Comp 11675.74 – 13.27 – 0.11% DJIA 33431.44 + 40.47 0.12% S&P500 VIX 18.61 + 0.12 0.65% U... |
FNArena | AVH | 1 year ago |
Weekly Ratings, Targets, Forecast Changes – 03-03-23
By Mark Woodruff Guide: The FNArena database tabulates the views of seven major Australian and international stock brokers: Citi, Credit Suisse, Macquarie, Morgan Stanley, Morgans, Ord Minnett and UBS. For the purpose of broker rating corre... |
FNArena | AVH | 1 year ago |
The Overnight Report: Not With A Bang
World Overnight SPI Overnight 7177.00 – 21.00 – 0.29% S&P ASX 200 7258.40 + 33.60 0.47% S&P500 3970.15 – 12.09 – 0.30% Nasdaq Comp 11455.54 – 11.44 – 0.10% DJIA 32656.70 – 232.39 – 0.71% S&P500 VIX 20.70 – 0.25 – 1... |
FNArena | AVH | 1 year ago |
Guess which ASX All Ordinaries stock has soared 50% in 3 days after reporting
The ASX All Ordinaries Index (ASX: XAO) has had a bumpy few days of trading recently. Last Friday, the All Ords rose by a decent 0.3%, only to tank by a nasty 1.2% yesterday. Today so far, the Index has bounced back up by 0.48%. But let’s... |
Motley Fool | AVH | 1 year ago |
The Overnight Report: Range-Bound?
World Overnight SPI Overnight 7201.00 + 34.00 0.47% S&P ASX 200 7224.80 – 82.20 – 1.12% S&P500 3982.24 + 12.20 0.31% Nasdaq Comp 11466.98 + 72.04 0.63% DJIA 32889.09 + 72.17 0.22% S&P500 VIX 20.95 – 0.72 – 3.32%... |
FNArena | AVH | 1 year ago |
CLOSING BELL: Shipments increase after China lifts the ban it never put on Aussie coal
The ASX fell today because US data gave Wall Street the willies on Friday A month’s worth of shipping data shows coal shipments to China are on the rise Qantas celebrates last week’s $1bn profit by slashing regional services. Again Toda... |
Stockhead | AVH | 1 year ago |
FNArena Corporate Results Monitor – 27-02-2023
Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((ASB)) - Austal ((AFG)) - Australian Finance Group ((AVH)) - Avita Medical ((BRI)) - Big River Industries ((SQ2)) - Block ((BXB)) - Brambles ((CB... |
FNArena | AVH | 1 year ago |
Four sectors trading at least 1% higher; ASX up 0.35% at noon
ShareCafeFour sectors trading at least 1% higher; ASX up 0.35% at noon by Peter Milios Industrials, Information Technology, Utilities and Real Estate are trading at least 1 per cent higher, responding to strong figures from the US markets... |
ShareCafe | AVH | 1 year ago |
Stocks of the Hour: Resource Base, AVITA Medical, Selfwealth
24 Feb 2023 - A snapshot of the stocks on the move featuring Resource Base (ASX:RBX), AVITA Medical (ASX:AVH) and Selfwealth (ASX:SWF). |
FNN | AVH | 1 year ago |
Stocks of the Hour: RBX, AVH, SWF
ShareCafeStocks of the Hour: RBX, AVH, SWF Resource Base (ASX:RBX) has secured an option to acquire two highly prospective lithium projects in Québec. Resource Base Non-Executive Chairman, Maurice Feilich, commented... |
ShareCafe | AVH | 1 year ago |
3 ASX shares I dream of owning at the right price
There are many ASX shares vying for a position in my portfolio at any single point in time. Companies that exhibit impressive revenue growth, sell incredibly valuable products/services, and are leaders in their fields. However, as amazing... |
Motley Fool | AVH | 1 year ago |
Here’s why Morningstar reckons the ASX healthcare sector is on road to recovery
Morningstar sees ASX healthcare sector as fair value with some buying opportunities Healthcare stocks viewed as defensive and insulated from rising inflation Morningstar has several healthcare picks for 2023 with last year’s headwinds like... |
Stockhead | AVH | 1 year ago |
“Your Stock Request” – 22 December 2022
“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o... |
Fairmont Equities | AVH | 1 year ago |
AVITA Medical submits FDA PMA application to expand indication
Regenerative medicine company AVITA Medical (ASX:AVH) has announced the submission of a Premarket Approval application to the US FDA for its RECELL System. |
BiotechDispatch | AVH | 1 year ago |
Investing in ASX biotech ft. Dr Megan Baldwin & Jeremy Curnock Cook
Jeremy Curnock Cook is the Managing Director and founder of BioScience Managers, a funds management business specialising in biotechnology investments in Australia and globally. He is also a director of Avita Medical Inc (ASX: AVH). Jeremy... |
Rask Media | AVH | 1 year ago |
3 ASX All Ordinaries shares that defied today’s sell-off to leap higher
The All Ordinaries Index (ASX: XAO) fell 0.65% today, but three ASX shares charged higher. The Magnis Energy Technologies Ltd (ASX: MNS), Cettire Ltd (ASX: CTT) and Avita Medical Inc (ASX: AVH) share prices all outperformed the index tod... |
Motley Fool | AVH | 1 year ago |
AVITA Medical submits to US FDA with the goal of expanding indication for RECELL
Regenerative medicine company AVITA Medical (ASX:AVH) has submitted to the US FDA for premarket approval supplement application for its RECELL System. |
BiotechDispatch | AVH | 1 year ago |
Purpose-driven startups win big at Pause Awards
Purpose focused startups such as Great Wrap, Bare Cremation, and Separation Guide, are among the major winners of the annual Pause Awards. Held in Melbourne and backed by VicGov, the 5th annual Pause Awards recognise innovation and people b... |
Startup Daily | AVH | 1 year ago |
Is there an $8 billion ‘pot of gold at the end of the rainbow’ for investors in this ASX healthcare share?
Shares in the spray-on skin company Avita Medical Inc (ASX: AVH) closed 2.6% higher on Friday at $1.96. The ASX healthcare share may be down 42% over the year to date, but it appears to be making a comeback. The Avita share price is up a... |
Motley Fool | AVH | 1 year ago |
2 absolute bargain ASX shares to buy right now: analyst
Ask A Fund Manager The Motley Fool chats with the best in the industry so that you can get an insight into how the professionals think. In this edition, Bell Direct market analyst Grady Wulff names two cheap ASX shares to buy and one to ho... |
Motley Fool | AVH | 1 year ago |
Australian Broker Call *Extra* Edition – Nov 21, 2022
An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au... |
FNArena | AVH | 2 years ago |
ASX Close: US inflation surprise lifts stocks to five-month high
A global relief rally catapulted the ASX 200 to a five-month high after Wall Street celebrated a slowdown in inflation with its biggest advance since 2020. The S&P/ASX 200 wrapped up a strong week with a rise of 194 points or 2.79 pe... |
themarketherald.com.au | AVH | 2 years ago |
ScoPo’s Powerplays: Stress eases as ASX health stocks enjoy much needed rally
ASX health stocks extend weekly gains on Friday as markets rally on back of promising US inflation figures Wound care company Avita rises 24% and biotech Antisense is up 18% for past five days Fertility company Monash IVF provides solid H1... |
Stockhead | AVH | 2 years ago |
Avita Medical (ASX:AVH) bolsters revenue guidance, reduces quarterly net loss
Avita Medical (AVH) reports a 30-per-cent bump to year-on-year revenue over the September quarter of this yearOver the three-month period, the company posted $9 million in quarterly commercial revenue compared to just under $7 million over... |
themarketherald.com.au | AVH | 2 years ago |
ASX Update: Five-month high as inflation fears abate
Wall Street’s best night since 2020 fuelled strong gains on the ASX, powering the benchmark to its highest level since June. The S&P/ASX 200 rallied 163 points or 2.33 per cent by mid-session. The rally followed huge gains in the US... |
themarketherald.com.au | AVH | 2 years ago |
ASX Health Stocks: Patent updates from Cynata and Proteomics; Ramsay sees good times ahead
Cynata gets Notice of Allowance from US Patent Office Proteomics secures patent in Hong Kong Ramsay Healthcare and Avita gave solid quarterly updates Cynata and Proteomics’ patents update Cynata Therapeutics (ASX:CYP) rose 8pc this mornin... |
Stockhead | AVH | 2 years ago |
ASX 200 rises at open; Pinnacle up over 14%
Highlights Australian shares opened higher on Friday. The ASX 200 gained in the opening trade, rising 36.10 points, or 0.52%, to 7,000.10. On Thursday, the benchmark index ended 0.5% higher at 6,964 points. Australian... |
Kalkine Media | AVH | 2 years ago |
ASX Health Stocks: Avita makes crucial announcement on its pivotal RECELL trial, shares up 9pc
Avita Medical successfully achieved two co-primary endpoints Noxopharm received $5.011 million in R&D rebate Avita makes crucial progress in pivotal trial Avita Medical (ASX:AVH) announced that it has achieved the co-primary endpoints... |
Stockhead | AVH | 2 years ago |
“Your Stock Request” – 10 November 2022
“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o... |
Fairmont Equities | AVH | 2 years ago |
The ASX All Ords share that’s a better, cheaper buy than Polynovo: Wilsons
Analysts at Wilsons have put the spotlight on one All Ordinaries Index (ASX: XAO) share it prefers over the Polynovo Ltd (ASX: PNV) share price. Polynovo shares fell 3.23% today to $1.98. For perspective, the All Ordinaries Index climbed... |
Motley Fool | AVH | 2 years ago |
Innovation never sleeps: Franklin Templeton says watch these 5 big tech shifts this quarter
Franklin Templeton says innovation accelerates despite recessions, pandemic, wars Expect advancements in sectors like gene therapy and augmented reality in healthcare New ways to grab our attention are reinventing the media industry Frank... |
Stockhead | AVH | 2 years ago |
Check Up: Blood clots are a $55bn opportunity and these 2 ASX stocks are vying for a slice
Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re... |
Stockhead | AVH | 2 years ago |
AVITA Medical (ASX:AVH) appoints James Corbett as CEO
Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediatelyMr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience He... |
themarketherald.com.au | AVH | 2 years ago |
3 ASX All Ordinaries shares defying today’s rout to surge higher
The S&P/ASX All Ordinaries Index (ASX: XAO) is deep in the red today after a hot US inflation report sent Wall Street into a tailspin overnight. At the time of writing, the All Ords index has slipped 2.6% to 7,065 points. The S&P/A... |
Motley Fool | AVH | 2 years ago |
Market Highlights: US bans Nvidia chips in China; and 5 ASX small caps to watch on Friday
Local markets set to open higher, Friday Late rally sees the S&P 500 close ahead, first time in five days US China trade war flares as chipmaker banned Local shares are set to open higher on Friday. At 8am AEST, the ASX 200 Septembe... |
Stockhead | AVH | 2 years ago |
ScoPo’s Powerplays: Reporting season positive as ASX health stocks head in right direction
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. ASX health sector modestly up... |
Stockhead | AVH | 2 years ago |